A phase II randomized, double-blind trial of a polyvalent vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian (EOC), fallopian tube, or peritoneal cancer who are in second or third complete remission.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 5517-5517
Author(s):  
Paul Sabbatini ◽  
Lee-may Chen ◽  
Joseph A. Lucci ◽  
Kian Behbakht ◽  
Nicola M. Spirtos ◽  
...  
2007 ◽  
Vol 177 (4S) ◽  
pp. 35-35
Author(s):  
Gianluca Giannarini ◽  
Andrea Mogorovich ◽  
Girolamo Morelli ◽  
Maurizio De Maria ◽  
Francesca Manassero ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document